company background image
8CT logo

Cannabix Technologies DB:8CT Stock Report

Last Price

€0.36

Market Cap

€43.0m

7D

-4.2%

1Y

191.9%

Updated

03 Feb, 2025

Data

Company Financials

Cannabix Technologies Inc.

DB:8CT Stock Report

Market Cap: €43.0m

8CT Stock Overview

A technology company, develops marijuana and alcohol breathalyzer for employers, law enforcement, workplaces, and laboratories in the United States. More details

8CT fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Cannabix Technologies Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Cannabix Technologies
Historical stock prices
Current Share PriceCA$0.36
52 Week HighCA$0.58
52 Week LowCA$0.12
Beta2.29
1 Month Change63.06%
3 Month Change45.97%
1 Year Change191.94%
3 Year Change-24.27%
5 Year Change-17.31%
Change since IPO316.09%

Recent News & Updates

Recent updates

Shareholder Returns

8CTDE ElectronicDE Market
7D-4.2%3.4%2.1%
1Y191.9%-23.7%15.0%

Return vs Industry: 8CT exceeded the German Electronic industry which returned -23.7% over the past year.

Return vs Market: 8CT exceeded the German Market which returned 15% over the past year.

Price Volatility

Is 8CT's price volatile compared to industry and market?
8CT volatility
8CT Average Weekly Movement24.8%
Electronic Industry Average Movement5.5%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.3%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 8CT's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 8CT's weekly volatility (25%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
2011n/aRav Mlaitcannabixtechnologies.com

Cannabix Technologies Inc., a technology company, develops marijuana and alcohol breathalyzer for employers, law enforcement, workplaces, and laboratories in the United States. It develops tetrahydrocannabinol breath systems, including cannabix mass spectrum (MS) breath sampler for mass spectrometers, optimized for breath collection and ionization that replaces the chromatography step and offers clinical and toxicology laboratories that analyzes nonvolatile species in breath; and cannabix breath collection unit that collects breath samples from the field onto a novel cartridge, which is taken and analyzed with the MS breath sampler. The company offers Breath Logix (BR-LGX), an industrial series a fully automated breath alcohol screening system for employee, contractor, and visitor access control that is self-administered, non-invasive, and has both non-contact and direct straw modes.

Cannabix Technologies Inc. Fundamentals Summary

How do Cannabix Technologies's earnings and revenue compare to its market cap?
8CT fundamental statistics
Market cap€42.99m
Earnings (TTM)-€2.22m
Revenue (TTM)n/a

0.0x

P/S Ratio

-18.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8CT income statement (TTM)
RevenueCA$0
Cost of RevenueCA$0
Gross ProfitCA$0
Other ExpensesCA$3.33m
Earnings-CA$3.33m

Last Reported Earnings

Oct 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.029
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did 8CT perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/03 03:49
End of Day Share Price 2025/02/03 00:00
Earnings2024/10/31
Annual Earnings2024/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cannabix Technologies Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution